From a clinical point of view, the possibility of regulating the pancreatic AQP7 function, by the upregulation of AQP expression or possibly by gene transfer in rare cases of loss-of-function mutations of the AQP7 gene, may also be beneficial in obesity, insulin resistance and type 2 diabetes. Here, AQP7 is linked to type 2 diabetes mellitus.